Regulatory information- ADDvise signs Letter of Intent regarding acquisition of a Finnish Med-Tech Company
· ADDvise Group AB (publ) (“ADDvise”) has signed a Letter of Intent with the shareholders of a Helsinki based med-tech company within the Life Science Industry (“the Company”) regarding the acquisition of 100 percent of the shares in the Company (the “Acquisition”). · The Company is a distribution company within the healthcare sector focusing mainly on sales and services of high-quality med-tech equipment. · The Company’s financial forecast for 2018: ca. 67,0 MSEK in revenue with an adjusted EBITDA of ca. 7,2 MSEK. · The purchase price amounts to ca. 33,0 MSEK based on cash and